Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


01.01.2018

4 Ann Rheum Dis
3 Arthritis Res Ther
1 Clin Exp Rheumatol
5 Clin Rheumatol
1 Drugs
1 Intern Med
1 J Immunol
7 J Rheumatol
4 PLoS One
3 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. CURTIS JR, Xie F, Chen L, Saag KG, et al
    Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
    Ann Rheum Dis. 2017 Dec 21. pii: annrheumdis-2017-211727.
    PubMed     Text format     Abstract available

  2. MATSUNO H, Tomomitsu M, Hagino A, Shin S, et al
    Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding
    Ann Rheum Dis. 2017 Dec 19. pii: annrheumdis-2017-212172.
    PubMed     Text format     Abstract available

  3. FRAENKEL L, Nowell WB, Michel G, Wiedmeyer C, et al
    Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212407.
    PubMed     Text format     Abstract available

  4. CORDTZ RL, Hawley S, Prieto-Alhambra D, Hojgaard P, et al
    Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212424.
    PubMed     Text format     Abstract available


    Arthritis Res Ther

  5. OUBOUSSAD L, Hunt L, Hensor EMA, Nam JL, et al
    Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:288.
    PubMed     Text format     Abstract available

  6. CHO SK, Lee J, Han M, Bae SC, et al
    The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.
    Arthritis Res Ther. 2017;19:277.
    PubMed     Text format     Abstract available

  7. CURTIS JR, Winthrop K, O'Brien C, Ndlovu MN, et al
    Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment.
    Arthritis Res Ther. 2017;19:276.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  8. CHUA JR, Castrejon I, Pincus T
    Assessment of pain and other patient symptoms in routine clinical care as quantitative, standardised, "scientific" data.
    Clin Exp Rheumatol. 2017;35 Suppl 107:13-20.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  9. BARBOSA-COBOS RE, Lugo-Zamudio G, Flores-Estrada J, Becerril-Mendoza LT, et al
    Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 18. pii: 10.1007/s10067-017-3929.
    PubMed     Text format     Abstract available

  10. RAMIREZ-FLORENCIO M, Jimenez-Morales S, Barbosa-Cobos RE, Lopez-Cano DJ, et al
    High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 20. pii: 10.1007/s10067-017-3955.
    PubMed     Text format     Abstract available

  11. GALARZA-DELGADO DA, Villegas Gonzalez MJ, Riega Torres J, Soto-Galindo GA, et al
    Early hearing loss detection in rheumatoid arthritis and primary Sjogren syndrome using extended high frequency audiometry.
    Clin Rheumatol. 2017 Dec 22. pii: 10.1007/s10067-017-3959.
    PubMed     Text format     Abstract available

  12. KUUSALO L, Puolakka K, Kautiainen H, Karjalainen A, et al
    High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 26. pii: 10.1007/s10067-017-3958.
    PubMed     Text format     Abstract available

  13. SANTOS AM, Saldarriaga EL, Giraldo-Bustos R, Ballesteros-Munoz JG, et al
    Dickkopf 1 protein circulating levels as a possible biomarker of functional disability and chronic damage in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 27. pii: 10.1007/s10067-017-3957.
    PubMed     Text format     Abstract available


    Drugs

  14. SCOTT LJ
    Correction to: Tocilizumab: A Review in Rheumatoid Arthritis.
    Drugs. 2017 Dec 19. pii: 10.1007/s40265-017-0856.
    PubMed     Text format     Abstract available


    Intern Med

  15. SABURI M, Ogata M, Yoshida N, Nashimoto Y, et al
    Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis.
    Intern Med. 2017 Dec 27. doi: 10.2169/internalmedicine.9599.
    PubMed     Text format     Abstract available


    J Immunol

  16. TANAKA Y, Sotome T, Inoue A, Mukozu T, et al
    SATB1 Conditional Knockout Results in Sjogren's Syndrome in Mice.
    J Immunol. 2017;199:4016-4022.
    PubMed     Text format     Abstract available


    J Rheumatol

  17. KAELEY GS, Evangelisto AM, Nishio MJ, Goss SL, et al
    Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial.
    J Rheumatol. 2016 Jun 15. pii: jrheum.151009.
    PubMed     Text format     Abstract available

  18. VERSTAPPEN GM, Kroese FG, Meiners PM, Corneth OB, et al
    B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjogren Syndrome.
    J Rheumatol. 2017;44:49-58.
    PubMed     Text format     Abstract available

  19. MOERMAN RV, Arends S, Meiners PM, Vissink A, et al
    Detailed Analysis of the Articular Domain in Patients with Primary Sjogren Syndrome.
    J Rheumatol. 2017;44:292-296.
    PubMed     Text format     Abstract available

  20. XU B, Li J, Wu C, Liu C, et al
    CXCL10 and TRAIL Are Upregulated by TXNDC5 in Rheumatoid Arthritis Fibroblast-like Synoviocytes.
    J Rheumatol. 2017 Dec 15. pii: jrheum.170170. doi: 10.3899/jrheum.170170.
    PubMed     Text format     Abstract available

  21. KIVITZ A, Olech E, Borofsky MA, Zazueta B, et al
    Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
    J Rheumatol. 2017 Dec 15. pii: jrheum.161539. doi: 10.3899/jrheum.161539.
    PubMed     Text format     Abstract available

  22. KAM NW, Liu D, Cai Z, Mak WY, et al
    Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis.
    J Rheumatol. 2017 Dec 15. pii: jrheum.161363. doi: 10.3899/jrheum.161363.
    PubMed     Text format     Abstract available

  23. MANDL T, Jorgensen TS, Skougaard M, Olsson P, et al
    Work Disability in Newly Diagnosed Patients with Primary Sjogren Syndrome.
    J Rheumatol. 2017;44:209-215.
    PubMed     Text format     Abstract available


    PLoS One

  24. HORNBERG K, Sundstrom B, Innala L, Rantapaa-Dahlqvist S, et al
    Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease.
    PLoS One. 2017;12:e0190211.
    PubMed     Text format     Abstract available

  25. DUHN PH, Sode J, Hagen CM, Christiansen M, et al
    Mitochondrial haplogroups in patients with rheumatoid arthritis: No association with disease and disease manifestations.
    PLoS One. 2017;12:e0188492.
    PubMed     Text format     Abstract available

  26. WANG B, Zhao P, Zhou Y, Meng L, et al
    Increased expression of Th17 cytokines and interleukin-22 correlates with disease activity in pristane-induced arthritis in rats.
    PLoS One. 2017;12:e0188199.
    PubMed     Text format     Abstract available

  27. SCHAAL JB, Tran DQ, Subramanian A, Patel R, et al
    Suppression and resolution of autoimmune arthritis by rhesus theta-defensin-1, an immunomodulatory macrocyclic peptide.
    PLoS One. 2017;12:e0187868.
    PubMed     Text format     Abstract available


    Rheumatol Int

  28. SANTOS-MORENO P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, et al
    A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. Experience of a Center of Excellence in Colombia.
    Rheumatol Int. 2017 Dec 16. pii: 10.1007/s00296-017-3903.
    PubMed     Text format     Abstract available

  29. FORSYTH C, Kouvari M, D'Cunha NM, Georgousopoulou EN, et al
    The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies.
    Rheumatol Int. 2017 Dec 18. pii: 10.1007/s00296-017-3912.
    PubMed     Text format     Abstract available

  30. PEREZ-ROMAN DI, Ortiz-Haro AB, Ruiz-Medrano E, Contreras-Yanez I, et al
    Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
    Rheumatol Int. 2017 Dec 20. pii: 10.1007/s00296-017-3910.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: